Shortly before the government-funding bill passed, Republican strategist Doug Heye said there simply wasn’t enough time to ...

House lawmakers voted 366-34 to pass a spending bill on Friday. The Senate passed it on a 85-11 vote. The bill, which funds ...

To encourage robust, good-faith discussion about issues raised in First Opinion essays, STAT publishes selected Letters to ...

The FDA has cleared Eli Lilly’s obesity drug Zepbound as the first treatment for obstructive sleep apnea in the U.S.

New clinical trial data from Novo Nordisk raise questions for the broad landscape of obesity drug development and the way ...

The treatment, called CagriSema, led patients to lose 20% of their weight at 68 weeks in a late-stage study when looking at ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Ionis won FDA approval for a drug for patients with a deadly genetic disease that impedes the body’s ability to break down ...

Gilead Sciences will no longer provide four HIV medicines for free as part of a patient assistance program starting at the ...

The FDA on Thursday confirmed that a shortage of Eli Lilly’s obesity drug tirzepatide has been resolved, a move that will put ...

Reports that cows have been infected despite farmers' preventive measures indicate there are multiple routes of transmission ...

After two recent deaths in gene therapy clinical trials, the industry needs to be more open to sharing information to protect ...